CFTR F508del binds components of the ERAD machinery for ubiquitination and degradation

Stable Identifier
R-HSA-8866857
Type
Reaction [binding]
Species
Homo sapiens
Compartment
endoplasmic reticulum membrane
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
CFTR F508del binds components of the ERAD machinery for ubiquitination and degradation
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Deletion of phenylalanine 508 in CFTR is the most prevalent mutation causing cystic fibrosis (Riordan et al, 1989; Kerem et al, 1989). F508 deletion causes destabilization and subsequent targeting for co-translational degradation by the ER-associated degradation machinery (ERAD). Like misfolded WT CFTR protein, F508del is ubiquitinated by ERAD-associated E3 ligases including RNF5 and RNF 185, targeting it for VCP-mediated retrotranslocation and 26S proteasomal degradation (Meachem et al, 2001; Rosser et al, 2008; Younger et al, 2004; Younger et al, 2006; El Khouri et al, 2013; reviewed in Pranke and Sermet-Gaudelus, 2014).
Literature References
PubMed ID Title Journal Year
24019521 RNF185 is a novel E3 ligase of endoplasmic reticulum-associated degradation (ERAD) that targets cystic fibrosis transmembrane conductance regulator (CFTR)

El Khouri, E, Le Pavec, G, Toledano, MB, Delaunay-Moisan, A

J. Biol. Chem. 2013
15611333 A foldable CFTR{Delta}F508 biogenic intermediate accumulates upon inhibition of the Hsc70-CHIP E3 ubiquitin ligase

Younger, JM, Ren, HY, Chen, L, Fan, CY, Fields, A, Patterson, C, Cyr, DM

J. Cell Biol. 2004
16901789 Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator

Younger, JM, Chen, L, Ren, HY, Rosser, MF, Turnbull, EL, Fan, CY, Patterson, C, Cyr, DM

Cell 2006
18716059 Assembly and misassembly of cystic fibrosis transmembrane conductance regulator: folding defects caused by deletion of F508 occur before and after the calnexin-dependent association of membrane spanning domain (MSD) 1 and MSD2

Rosser, MF, Grove, DE, Chen, L, Cyr, DM

Mol. Biol. Cell 2008
2475911 Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

Riordan, JR, Rommens, JM, Kerem, B, Alon, N, Rozmahel, R, Grzelczak, Z, Zielenski, J, Lok, S, Plavsic, N, Chou, JL

Science 1989
11146634 The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation

Meacham, GC, Patterson, C, Zhang, W, Younger, JM, Cyr, DM

Nat. Cell Biol. 2001
24685677 Biosynthesis of cystic fibrosis transmembrane conductance regulator

Pranke, IM, Sermet-Gaudelus, I

Int. J. Biochem. Cell Biol. 2014
2570460 Identification of the cystic fibrosis gene: genetic analysis

Kerem, B, Rommens, JM, Buchanan, JA, Markiewicz, D, Cox, TK, Chakravarti, A, Buchwald, M, Tsui, LC

Science 1989
Participants
Input
Output
Participates
as an event of
Normal reaction
CFTR binds components of the ERAD machinery for ubiquitination and degradation (Homo sapiens)
Functional status

Gain of function of CFTR F508del [endoplasmic reticulum membrane]

Normal Entity
Disease Entity
Status
Disease
Name Identifier Synonyms
cystic fibrosis DOID:1485 mucoviscidosis, CF
Cross References
Mondo
Authored
Rothfels, K  (2016-04-02)
Reviewed
D'Eustachio, P  (2016-04-23)
Created
Rothfels, K  (2016-04-04)
Cite Us!